KMDA Q2 2021 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

Q2 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$24M-26.7% YoY

Gross Profit

$9M37.4% margin

Operating Income

$1M4.3% margin

Net Income

$937,0003.9% margin

EPS (Diluted)

$0.02

QoQ Revenue Growth

-2.7%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$5M

Stock-Based Comp.

$155,000

Balance Sheet

Total Assets

$216M

Total Liabilities

$34M

Stockholders' Equity

$182M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$33M	-26.7%
Gross Profit	$9M	$11M	-18.4%
Operating Income	$1M	$4M	-73.7%
Net Income	$937,000	$3M	-72.9%